Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giulia Venturi
Observed names:
GIULIA VENTURI,
Venturi, Giulia
Institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Azienda Ospedaliero-Universitaria Careggi,
University of Southampton,
University of Florence,
University of Bologna
ORCID:
0000-0002-1624-8946
Observed ORCID:
0000-0002-1624-8946
OpenAlex ID:
A5003564401
Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
2018
·
Inês Gomes Ferreira
, Michela Pucci
, et al.
·
International Journal of Molecular Sciences
·
136
PDF
Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis
2016
·
Massimiliano Mellone
, Christopher J. Hanley
, et al.
·
Aging
·
120
How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies
2020
·
Giulia Venturi
, Lorenzo Montanaro
·
Cells
·
68
PDF
Identification of novel plasma glycosylation-associated markers of aging
2016
·
Mariangela Catera
, Vincenzo Borelli
, et al.
·
Oncotarget
·
50
PDF
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status
2024
·
Andrea De Giglio
, Dario De Biase
, et al.
·
Lung Cancer
·
41
PDF
ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
2022
·
Massimiliano Mellone
, Klaudia Piotrowska
, et al.
·
Cancer Research
·
38
PDF
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types
2019
·
Giulia Venturi
, Inês Gomes Ferreira
, et al.
·
Glycobiology
·
33
PDF
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies
2024
·
Giandomenico Roviello
, Irene De Gennaro
, et al.
·
Genes
·
30
PDF
How snoRNAs can contribute to cancer at multiple levels
2024
·
Federico Zacchini
, Chiara Barozzi
, et al.
·
NAR Cancer
·
23
PDF
Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage
2017
·
Paulo F. Severino
, Mariana Silva
, et al.
·
Oncotarget
·
23
PDF
Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy
2024
·
Valerio Gelfo
, Giulia Venturi
, et al.
·
Biomedicines
·
18
PDF
Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1
2018
·
Paulo F. Severino
, Mariana Silva
, et al.
·
BMC Cancer
·
15
PDF
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients
2022
·
Stefano Gitto
, Francesco Vizzutti
, et al.
·
Digestive and Liver Disease
·
14
PDF
Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence
2022
·
Federico Zacchini
, Giulia Venturi
, et al.
·
Genome biology
·
12
PDF
N-Glycan on the Non-Consensus N-X-C Glycosylation Site Impacts Activity, Stability, and Localization of the Sda Synthase B4GALNT2
2023
·
Virginie Cogez
, Dorothée Vicogne
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Analysis of the proximal promoter of the human colon-specific B4GALNT2 (Sda synthase) gene: B4GALNT2 is transcriptionally regulated by ETS1
2021
·
Cindy Wavelet-Vermuse
, Sophie Groux-Degroote
, et al.
·
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
·
7
PDF
Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells
2025
·
Guglielmo Rambaldelli
, Sidra Asghar
, et al.
·
Non-coding RNA Research
·
6
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
2024
·
Marzia Del Re
, Stefania Crucitta
, et al.
·
Clinical Genitourinary Cancer
·
6
Incidence and impact of immune combination therapies adverse events in advanced renal cell carcinoma patients
2025
·
Martina Catalano
, Giulia Venturi
, et al.
·
Immunotherapy
·
4
PDF
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report
2024
·
Andrea De Giglio
, Federico Zacchini
, et al.
·
The Journal of Liquid Biopsy
·
4
PDF
5.8S rRNA forms and ribosome heterogeneity in breast cancer
2025
·
Giulia Venturi
, Federico Zacchini
, et al.
·
Biochimie
·
3
Primer extension coupled with fragment analysis for rapid and quantitative evaluation of 5.8S rRNA isoforms
2021
·
Giulia Venturi
, Federico Zacchini
, et al.
·
PLoS ONE
·
3
PDF
Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma
2024
·
ELISABETTA GAMBALE
, GIULIA VENTURI
, et al.
·
Cancer Diagnosis & Prognosis
·
2
PDF
NMR metabolomics in bladder cancer: Identification and monitoring of serum biomarkers during Pt-based treatment.
2023
·
Roberta Giorgione
, Elisabetta Gambale
, et al.
·
Journal of Clinical Oncology
·
1
PDF
The impact of ST6Gal-I in the progression of colorectal cancer
2018
·
Venturi, Giulia
·
AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
·
1
PDF
Show more works
View as search
Works count:
60
Citation count:
669
H-index:
13
I10-index:
15
Year
Topic
Type